Back to Search
REGINA PLUMMER, DO
DO
Anatomic Pathology & Clinical Pathology Physician
NPI: 1265810287IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
2360(NE)
CMS Specialties
PrimaryPATHOLOGY
Education
KANSAS CITY UNIVERSITY OF MED & BIOSCIENCES, COLLEGE OF OSTEO MED
Class of 2015
Research & Publications (20)
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
PMID 19383817·Clin Cancer Res·2009
3-trial
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
PMID 19088046·Clin Cancer Res·2008
3-trial
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.
PMID 19047122·Clin Cancer Res·2008
3-trial
Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers.
PMID 17947486·Clin Cancer Res·2007
3-trial
Modelling Staphylococcus aureus-induced septicemia using NMR.
PMID 17899589·Magn Reson Med·2007
8-other
Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopy.
PMID 17785514·Antimicrob Agents Chemother·2007
8-other
Exploring co-management theory: prospects for sociobiology and reciprocal altruism.
PMID 17196324·J Environ Manage·2007
8-other
Some observations on the terminology in co-operative environmental management.
PMID 15125546·J Environ Manage·2004
8-other
A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor.
PMID 12684399·Clin Cancer Res·2003
3-trial
Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies.
PMID 12231518·Clin Cancer Res·2002
3-trial
Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.
PMID 18983540·Pigment Cell Melanoma Res·2008
6-review
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery).
PMID 18653327·Eur J Cancer·2008
3-trial
The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials.
PMID 18559580·Clin Cancer Res·2008
8-other
Geomicrobial characterization of gas hydrate-bearing sediments along the mid-Chilean margin.
PMID 18522645·FEMS Microbiol Ecol·2008
8-other
Mechanisms of chemoresistance to alkylating agents in malignant glioma.
PMID 18483356·Clin Cancer Res·2008
6-review
PAX genes: roles in development, pathophysiology, and cancer.
PMID 16904651·Biochem Pharmacol·2007
6-review
Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma.
PMID 12177114·J Clin Oncol·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8303 DODGE ST
OMAHA, NE 68114 - Phone
- (402) 354-4540
Quick Facts
- NPI
- 1265810287
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile